rabbit anti-src2 antibody Search Results


91
Bioss anti src2
Anti Src2, supplied by Bioss, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti src2/product/Bioss
Average 91 stars, based on 1 article reviews
anti src2 - by Bioz Stars, 2026-06
91/100 stars
  Buy from Supplier

99
LI-COR goatarabbit irdye 800cw
Goatarabbit Irdye 800cw, supplied by LI-COR, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goatarabbit irdye 800cw/product/LI-COR
Average 99 stars, based on 1 article reviews
goatarabbit irdye 800cw - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

86
Bethyl anti nuclear receptor coactivator 2 grip1
Anti Nuclear Receptor Coactivator 2 Grip1, supplied by Bethyl, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti nuclear receptor coactivator 2 grip1/product/Bethyl
Average 86 stars, based on 1 article reviews
anti nuclear receptor coactivator 2 grip1 - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

97
Santa Cruz Biotechnology anti c src
Anti C Src, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti c src/product/Santa Cruz Biotechnology
Average 97 stars, based on 1 article reviews
anti c src - by Bioz Stars, 2026-06
97/100 stars
  Buy from Supplier

93
Bethyl rabbit polyclonal anti tif2
Rabbit Polyclonal Anti Tif2, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal anti tif2/product/Bethyl
Average 93 stars, based on 1 article reviews
rabbit polyclonal anti tif2 - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc anti src 2
Anti Src 2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti src 2/product/Cell Signaling Technology Inc
Average 93 stars, based on 1 article reviews
anti src 2 - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology anti src rabbit polyclonal igg
Anti Src Rabbit Polyclonal Igg, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti src rabbit polyclonal igg/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
anti src rabbit polyclonal igg - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology anti src 2
Anti Src 2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti src 2/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
anti src 2 - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc anti csrc src2 rabbit igg
Anti Csrc Src2 Rabbit Igg, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti csrc src2 rabbit igg/product/Cell Signaling Technology Inc
Average 99 stars, based on 1 article reviews
anti csrc src2 rabbit igg - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

99
Abcam rabbit polyclonal anti src 2 antibody
(A) Dual immunofluorescence for GFP (green) and <t>SRC-2</t> (red) in the ARH of POMC-EGFP mice (controls, upper panels) and pomcSRC-2-KO/POMC-EGFP mice (lower panels). Arrowheads point to double-labeled neurons. Scale bar represents 100 μm. 3V, 3 rd ventricle; ARH, arcuate nucleus of the hypothalamus; ME, median eminence; VMH, ventromedial hypothalamic nucleus. (B and C) Changes in body weight (B), fat mass, or lean mass (C) of chow-fed male control and pomcSRC-2-KO littermates (3 to 4 months old) after a 24-h fasting. Data are presented as mean ± SEM (% baseline before fasting). n = 6 or 10 mice per group. **p < 0.01 in t tests. (D) Daily energy expenditure measured by CLAMS in male control and pomcSRC-2-KO littermates (3 months old) during ad libitum fed, fasted, and refed periods. Data are presented as mean ± SEM. n = 8 or 9 mice per group. *p < 0.05 and ***p < 0.001 in two-way ANOVA analyses repeated measurement followed by Sidak tests. (E) Representative microscopic images showing a recorded POMC neuron (GFP-labeled in POMC-EGFP mice). Scale bar represents 10 μm. (F) Representative action potential traces in POMC neurons from fasted control versus pomcSRC-2-KO mice. (G and H) Quantifications of firing rate (G) and resting membrane potential (H) in POMC neurons from fasted control versus pomcSRC-2-KO mice. Data are presented as mean ± SEM. n = 17 or 21 neurons from 3 mice per group. *p < 0.05 in t tests. (I) Representative traces for mIPSC recorded in POMC neurons from fasted control versus pomcSRC-2-KO mice. (J and K) Quantifications of frequency (J) and amplitude (K) of mIPSC. Data are presented as mean ± SEM. n = 15 or 17 neurons from 3 mice per group. *p < 0.05 in t tests. (L) Relative mRNA levels of indicated genes measured in POMC neurons isolated from control versus pomcSRC-2-KO mice. Data are presented as mean ± SEM. n = 8 samples per group. *p < 0.05 in t tests.
Rabbit Polyclonal Anti Src 2 Antibody, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal anti src 2 antibody/product/Abcam
Average 99 stars, based on 1 article reviews
rabbit polyclonal anti src 2 antibody - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

90
Becton Dickinson mouse anti-src2
Agarose-bound GST fusion proteins of ERRγ (1ug) were used to pull down whole cell lysates containing a fixed amount of SRC1 (A) or <t>SRC2</t> (B), mixed with increasing amounts of the wild-type GNL3L (A1, B1) or the dI mutant lacking the ERRγ-interacting domain (A2, B2). Whole cell proteins in each sample were adjusted to the same amount. In the agarose-retained portions (R), the interaction between GNL3L and ERRγ can reduce the amount of SRC1 and SRC2 bound by ERRγ in a dose-dependent manner, but the dI mutant fails to do so. Conversely, when GST-ERRγ fusion proteins were used to pull down the same amount of GNL3L in the presence of increasing amounts of SRC1 (C) or SRC2 (D), SRC1 and SRC2 were able to reduce the amount of GNL3L bound by ERRγ in a dose-dependent way as well. Proteins in the agarose-bound fraction and in the supernatant are indicated by (R) and (S), respectively.
Mouse Anti Src2, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-src2/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
mouse anti-src2 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

92
Cell Signaling Technology Inc anti h3k9me2
Agarose-bound GST fusion proteins of ERRγ (1ug) were used to pull down whole cell lysates containing a fixed amount of SRC1 (A) or <t>SRC2</t> (B), mixed with increasing amounts of the wild-type GNL3L (A1, B1) or the dI mutant lacking the ERRγ-interacting domain (A2, B2). Whole cell proteins in each sample were adjusted to the same amount. In the agarose-retained portions (R), the interaction between GNL3L and ERRγ can reduce the amount of SRC1 and SRC2 bound by ERRγ in a dose-dependent manner, but the dI mutant fails to do so. Conversely, when GST-ERRγ fusion proteins were used to pull down the same amount of GNL3L in the presence of increasing amounts of SRC1 (C) or SRC2 (D), SRC1 and SRC2 were able to reduce the amount of GNL3L bound by ERRγ in a dose-dependent way as well. Proteins in the agarose-bound fraction and in the supernatant are indicated by (R) and (S), respectively.
Anti H3k9me2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti h3k9me2/product/Cell Signaling Technology Inc
Average 92 stars, based on 1 article reviews
anti h3k9me2 - by Bioz Stars, 2026-06
92/100 stars
  Buy from Supplier

Image Search Results


(A) Dual immunofluorescence for GFP (green) and SRC-2 (red) in the ARH of POMC-EGFP mice (controls, upper panels) and pomcSRC-2-KO/POMC-EGFP mice (lower panels). Arrowheads point to double-labeled neurons. Scale bar represents 100 μm. 3V, 3 rd ventricle; ARH, arcuate nucleus of the hypothalamus; ME, median eminence; VMH, ventromedial hypothalamic nucleus. (B and C) Changes in body weight (B), fat mass, or lean mass (C) of chow-fed male control and pomcSRC-2-KO littermates (3 to 4 months old) after a 24-h fasting. Data are presented as mean ± SEM (% baseline before fasting). n = 6 or 10 mice per group. **p < 0.01 in t tests. (D) Daily energy expenditure measured by CLAMS in male control and pomcSRC-2-KO littermates (3 months old) during ad libitum fed, fasted, and refed periods. Data are presented as mean ± SEM. n = 8 or 9 mice per group. *p < 0.05 and ***p < 0.001 in two-way ANOVA analyses repeated measurement followed by Sidak tests. (E) Representative microscopic images showing a recorded POMC neuron (GFP-labeled in POMC-EGFP mice). Scale bar represents 10 μm. (F) Representative action potential traces in POMC neurons from fasted control versus pomcSRC-2-KO mice. (G and H) Quantifications of firing rate (G) and resting membrane potential (H) in POMC neurons from fasted control versus pomcSRC-2-KO mice. Data are presented as mean ± SEM. n = 17 or 21 neurons from 3 mice per group. *p < 0.05 in t tests. (I) Representative traces for mIPSC recorded in POMC neurons from fasted control versus pomcSRC-2-KO mice. (J and K) Quantifications of frequency (J) and amplitude (K) of mIPSC. Data are presented as mean ± SEM. n = 15 or 17 neurons from 3 mice per group. *p < 0.05 in t tests. (L) Relative mRNA levels of indicated genes measured in POMC neurons isolated from control versus pomcSRC-2-KO mice. Data are presented as mean ± SEM. n = 8 samples per group. *p < 0.05 in t tests.

Journal: Cell reports

Article Title: Hypothalamic steroid receptor coactivator-2 regulates adaptations to fasting and overnutrition

doi: 10.1016/j.celrep.2021.110075

Figure Lengend Snippet: (A) Dual immunofluorescence for GFP (green) and SRC-2 (red) in the ARH of POMC-EGFP mice (controls, upper panels) and pomcSRC-2-KO/POMC-EGFP mice (lower panels). Arrowheads point to double-labeled neurons. Scale bar represents 100 μm. 3V, 3 rd ventricle; ARH, arcuate nucleus of the hypothalamus; ME, median eminence; VMH, ventromedial hypothalamic nucleus. (B and C) Changes in body weight (B), fat mass, or lean mass (C) of chow-fed male control and pomcSRC-2-KO littermates (3 to 4 months old) after a 24-h fasting. Data are presented as mean ± SEM (% baseline before fasting). n = 6 or 10 mice per group. **p < 0.01 in t tests. (D) Daily energy expenditure measured by CLAMS in male control and pomcSRC-2-KO littermates (3 months old) during ad libitum fed, fasted, and refed periods. Data are presented as mean ± SEM. n = 8 or 9 mice per group. *p < 0.05 and ***p < 0.001 in two-way ANOVA analyses repeated measurement followed by Sidak tests. (E) Representative microscopic images showing a recorded POMC neuron (GFP-labeled in POMC-EGFP mice). Scale bar represents 10 μm. (F) Representative action potential traces in POMC neurons from fasted control versus pomcSRC-2-KO mice. (G and H) Quantifications of firing rate (G) and resting membrane potential (H) in POMC neurons from fasted control versus pomcSRC-2-KO mice. Data are presented as mean ± SEM. n = 17 or 21 neurons from 3 mice per group. *p < 0.05 in t tests. (I) Representative traces for mIPSC recorded in POMC neurons from fasted control versus pomcSRC-2-KO mice. (J and K) Quantifications of frequency (J) and amplitude (K) of mIPSC. Data are presented as mean ± SEM. n = 15 or 17 neurons from 3 mice per group. *p < 0.05 in t tests. (L) Relative mRNA levels of indicated genes measured in POMC neurons isolated from control versus pomcSRC-2-KO mice. Data are presented as mean ± SEM. n = 8 samples per group. *p < 0.05 in t tests.

Article Snippet: The blot was probed with anti-Flag-HRP (1:3,000–10,000, A8592, Sigma), rabbit polyclonal anti-SRC-2 antibody (1:1,000, ab10491, Abcam) or mouse monoclonal anti-β-Actin-HRP (1:5,000, #12262, Cell Signaling), and the secondary antibody was goat anti-rabbit IgG (Jackson ImmunoResearch), followed by development with the SuperSignal West Pico Chemiluminescent Substrate (Pierce).

Techniques: Immunofluorescence, Labeling, Isolation

(A) Effects of SRC-2 on POMC-luciferase activity in “fed” and fasted cells. Data are presented as mean ± SEM. n = 4 or 5 repeated experiments with 6 biological replicates per group in each experiment. *p < 0.05 and ***p < 0.001 in two-way ANOVA analyses followed by Sidak tests. (B) Effects of SRC-2 on POMC-luciferase activity in fasted cells with or without FoxO1 knockdown. Data are presented as mean ± SEM. n = 4–7 repeated experiments with 6 biological replicates per group in each experiment. ***p < 0.001 in two-way ANOVA analyses followed by Sidak tests. (C) Hypothalamic mRNAs in fasted control and pomcSRC-2-KO mice. Data are presented as mean ± SEM. n = 14 or 15 mice per group. *p < 0.05 in t tests. (D) Interaction of endogenous SRC-2 and FoxO1 in the hypothalamus from chow- or HFD-fed male mice. (E) Body weight curves in male control and pomcSRC-2-KO littermates fed HFD ad libitum since 7 weeks of age. Data are presented as mean ± SEM. n = 8 mice per group. *p < 0.05 in two-way ANOVA analyses repeated measurement followed by Sidak tests. (F) Fat or lean mass in 14-week-old male control and pomcSRC-2-KO littermates after 7 weeks HFD feeding. Data are presented as mean ± SEM. n = 8 mice per group. *p < 0.05 in t tests. (G) Cumulative HFD intake in male control and pomcSRC-2-KO littermates fed HFD ad libitum since 7 weeks of age. Data are presented as mean ± SEM. n = 8 mice per group. *p < 0.05 in two-way ANOVA analyses repeated measurement followed by Sidak tests. (H) Changes in body weight during a 3-week HFD feeding in mice receiving stereotaxic injections of AAV-FLEX-FoxO1 AAA or AAV-GFP into the ARH. Data are presented as mean ± SEM. n = 6–10 mice per group. * or #, p < 0.05 between POMC-Cre+ AAV-FLEX-FoxO1 AAA versus WT+ AAV-FLEX-FoxO1 AAA or versus pomcSRC-2-KO+AAV-FLEX-FoxO1 AAA in two-way ANOVA analyses repeated measurement followed by Sidak tests. (I and J) Changes in body weight (I) and fat mass (J) at the end of the 3-week HFD feeding in mice described in (H). Data are presented as mean ± SEM. n = 6–10 mice per group. *p < 0.05 in two-way ANOVA analyses followed by Sidak tests; p = 0.09 in t tests. (K) Cumulative HFD intake in mice described in (H). Data are presented as mean ± SEM. n = 6–10 mice per group. * or #, p < 0.05 between POMC-Cre+ AAV-FLEX-FoxO1 AAA versus WT+ AAV-FLEX-FoxO1 AAA or versus pomcSRC-2-KO+AAV-FLEX-FoxO1 AAA in two-way ANOVA analyses repeated measurement followed by Sidak tests.

Journal: Cell reports

Article Title: Hypothalamic steroid receptor coactivator-2 regulates adaptations to fasting and overnutrition

doi: 10.1016/j.celrep.2021.110075

Figure Lengend Snippet: (A) Effects of SRC-2 on POMC-luciferase activity in “fed” and fasted cells. Data are presented as mean ± SEM. n = 4 or 5 repeated experiments with 6 biological replicates per group in each experiment. *p < 0.05 and ***p < 0.001 in two-way ANOVA analyses followed by Sidak tests. (B) Effects of SRC-2 on POMC-luciferase activity in fasted cells with or without FoxO1 knockdown. Data are presented as mean ± SEM. n = 4–7 repeated experiments with 6 biological replicates per group in each experiment. ***p < 0.001 in two-way ANOVA analyses followed by Sidak tests. (C) Hypothalamic mRNAs in fasted control and pomcSRC-2-KO mice. Data are presented as mean ± SEM. n = 14 or 15 mice per group. *p < 0.05 in t tests. (D) Interaction of endogenous SRC-2 and FoxO1 in the hypothalamus from chow- or HFD-fed male mice. (E) Body weight curves in male control and pomcSRC-2-KO littermates fed HFD ad libitum since 7 weeks of age. Data are presented as mean ± SEM. n = 8 mice per group. *p < 0.05 in two-way ANOVA analyses repeated measurement followed by Sidak tests. (F) Fat or lean mass in 14-week-old male control and pomcSRC-2-KO littermates after 7 weeks HFD feeding. Data are presented as mean ± SEM. n = 8 mice per group. *p < 0.05 in t tests. (G) Cumulative HFD intake in male control and pomcSRC-2-KO littermates fed HFD ad libitum since 7 weeks of age. Data are presented as mean ± SEM. n = 8 mice per group. *p < 0.05 in two-way ANOVA analyses repeated measurement followed by Sidak tests. (H) Changes in body weight during a 3-week HFD feeding in mice receiving stereotaxic injections of AAV-FLEX-FoxO1 AAA or AAV-GFP into the ARH. Data are presented as mean ± SEM. n = 6–10 mice per group. * or #, p < 0.05 between POMC-Cre+ AAV-FLEX-FoxO1 AAA versus WT+ AAV-FLEX-FoxO1 AAA or versus pomcSRC-2-KO+AAV-FLEX-FoxO1 AAA in two-way ANOVA analyses repeated measurement followed by Sidak tests. (I and J) Changes in body weight (I) and fat mass (J) at the end of the 3-week HFD feeding in mice described in (H). Data are presented as mean ± SEM. n = 6–10 mice per group. *p < 0.05 in two-way ANOVA analyses followed by Sidak tests; p = 0.09 in t tests. (K) Cumulative HFD intake in mice described in (H). Data are presented as mean ± SEM. n = 6–10 mice per group. * or #, p < 0.05 between POMC-Cre+ AAV-FLEX-FoxO1 AAA versus WT+ AAV-FLEX-FoxO1 AAA or versus pomcSRC-2-KO+AAV-FLEX-FoxO1 AAA in two-way ANOVA analyses repeated measurement followed by Sidak tests.

Article Snippet: The blot was probed with anti-Flag-HRP (1:3,000–10,000, A8592, Sigma), rabbit polyclonal anti-SRC-2 antibody (1:1,000, ab10491, Abcam) or mouse monoclonal anti-β-Actin-HRP (1:5,000, #12262, Cell Signaling), and the secondary antibody was goat anti-rabbit IgG (Jackson ImmunoResearch), followed by development with the SuperSignal West Pico Chemiluminescent Substrate (Pierce).

Techniques: Luciferase, Activity Assay

Journal: Cell reports

Article Title: Hypothalamic steroid receptor coactivator-2 regulates adaptations to fasting and overnutrition

doi: 10.1016/j.celrep.2021.110075

Figure Lengend Snippet:

Article Snippet: The blot was probed with anti-Flag-HRP (1:3,000–10,000, A8592, Sigma), rabbit polyclonal anti-SRC-2 antibody (1:1,000, ab10491, Abcam) or mouse monoclonal anti-β-Actin-HRP (1:5,000, #12262, Cell Signaling), and the secondary antibody was goat anti-rabbit IgG (Jackson ImmunoResearch), followed by development with the SuperSignal West Pico Chemiluminescent Substrate (Pierce).

Techniques: Recombinant, Enzyme-linked Immunosorbent Assay, Luciferase, Transgenic Assay

Agarose-bound GST fusion proteins of ERRγ (1ug) were used to pull down whole cell lysates containing a fixed amount of SRC1 (A) or SRC2 (B), mixed with increasing amounts of the wild-type GNL3L (A1, B1) or the dI mutant lacking the ERRγ-interacting domain (A2, B2). Whole cell proteins in each sample were adjusted to the same amount. In the agarose-retained portions (R), the interaction between GNL3L and ERRγ can reduce the amount of SRC1 and SRC2 bound by ERRγ in a dose-dependent manner, but the dI mutant fails to do so. Conversely, when GST-ERRγ fusion proteins were used to pull down the same amount of GNL3L in the presence of increasing amounts of SRC1 (C) or SRC2 (D), SRC1 and SRC2 were able to reduce the amount of GNL3L bound by ERRγ in a dose-dependent way as well. Proteins in the agarose-bound fraction and in the supernatant are indicated by (R) and (S), respectively.

Journal:

Article Title: GNL3L Inhibits Estrogen Receptor-Related Protein Activities by Competing for Coactivator Binding

doi: 10.1242/jcs.009878

Figure Lengend Snippet: Agarose-bound GST fusion proteins of ERRγ (1ug) were used to pull down whole cell lysates containing a fixed amount of SRC1 (A) or SRC2 (B), mixed with increasing amounts of the wild-type GNL3L (A1, B1) or the dI mutant lacking the ERRγ-interacting domain (A2, B2). Whole cell proteins in each sample were adjusted to the same amount. In the agarose-retained portions (R), the interaction between GNL3L and ERRγ can reduce the amount of SRC1 and SRC2 bound by ERRγ in a dose-dependent manner, but the dI mutant fails to do so. Conversely, when GST-ERRγ fusion proteins were used to pull down the same amount of GNL3L in the presence of increasing amounts of SRC1 (C) or SRC2 (D), SRC1 and SRC2 were able to reduce the amount of GNL3L bound by ERRγ in a dose-dependent way as well. Proteins in the agarose-bound fraction and in the supernatant are indicated by (R) and (S), respectively.

Article Snippet: Western analyses were performed using the mouse anti-Myc, rabbit anti-HA, rabbit anti-SRC1 (abcam, ab2859, 500X), and mouse anti-SRC2 (BD Transduction Laboratories, clone 29, 250X) antibodies.

Techniques: Mutagenesis

(A) The GNL3L effect on the DNA binding of ERRγ was examined by electrophoretic mobility shift assays (EMSA) using ERE-containing probes and whole cell lysates expressing the indicated recombinant proteins. Compared to the probe alone (lane 1) and the vector-transfected control sample (lane 2), the ERRγ-specific DNA-protein complex can be identified in lane 3 (arrow b), competed by excess non-labeled probes (lane 4), and supershifted by anti-Myc antibody (lane 5, arrow a). Coexpression of GNL3L produces fast-moving complexes (lane 6, arrows d and e), which can be supershifted by anti-Myc antibody (lane 7, arrow c) but not by anti-HA antibody (lane 8). GNL3L itself cannot bind the ERE probe (lane 9). The intensity of the fast-moving complex d is reduced by a deletion of the ERRγ-binding I-domain of GNL3L (lanes 10–12). (B) The fast-moving complex d and the slow-moving complex b were retrieved from the EMSA gel, fractionated in SDS-denaturing PAGE, and analyzed for their ERRγ (α-Myc), GNL3L (α-HA), SRC1, and SRC2 protein components by western blottings. Our results indicate that the increase in the electrophoretic mobility of the ERRγ-DNA complex by GNL3L coexpression can be explained by a loss of SRC1 binding (arrow) and diminished SRC2 binding, rather than by protein cleavage of ERRγ.

Journal:

Article Title: GNL3L Inhibits Estrogen Receptor-Related Protein Activities by Competing for Coactivator Binding

doi: 10.1242/jcs.009878

Figure Lengend Snippet: (A) The GNL3L effect on the DNA binding of ERRγ was examined by electrophoretic mobility shift assays (EMSA) using ERE-containing probes and whole cell lysates expressing the indicated recombinant proteins. Compared to the probe alone (lane 1) and the vector-transfected control sample (lane 2), the ERRγ-specific DNA-protein complex can be identified in lane 3 (arrow b), competed by excess non-labeled probes (lane 4), and supershifted by anti-Myc antibody (lane 5, arrow a). Coexpression of GNL3L produces fast-moving complexes (lane 6, arrows d and e), which can be supershifted by anti-Myc antibody (lane 7, arrow c) but not by anti-HA antibody (lane 8). GNL3L itself cannot bind the ERE probe (lane 9). The intensity of the fast-moving complex d is reduced by a deletion of the ERRγ-binding I-domain of GNL3L (lanes 10–12). (B) The fast-moving complex d and the slow-moving complex b were retrieved from the EMSA gel, fractionated in SDS-denaturing PAGE, and analyzed for their ERRγ (α-Myc), GNL3L (α-HA), SRC1, and SRC2 protein components by western blottings. Our results indicate that the increase in the electrophoretic mobility of the ERRγ-DNA complex by GNL3L coexpression can be explained by a loss of SRC1 binding (arrow) and diminished SRC2 binding, rather than by protein cleavage of ERRγ.

Article Snippet: Western analyses were performed using the mouse anti-Myc, rabbit anti-HA, rabbit anti-SRC1 (abcam, ab2859, 500X), and mouse anti-SRC2 (BD Transduction Laboratories, clone 29, 250X) antibodies.

Techniques: Binding Assay, Electrophoretic Mobility Shift Assay, Expressing, Recombinant, Plasmid Preparation, Transfection, Labeling, Western Blot

(A) Using the same cell-based reporter system as described in Fig. 4, we show that the ERE-specific transcriptional activity in cells coexpressing ERRγ and SRC1 (8.0±0.3) is 1.7 times higher than that of the ERRγ-expressing sample (4.8±0.3). When coexpressed with the wild-type GNL3L (WT), this ERRγ and SRC1-mediated ERE-specific transcriptional activity is reduced by 55 and 70 percent compared to the sample expressing both ERRγ and SRC1 in a dose-dependent manner. This inhibitory effect of GNL3L on the SRC1-mediated coactivation of ERRγ requires the I-domain of GNL3L, as a deletion of this domain (dI) fails to suppress the transcriptional activity of ERRγ and SRC1 (P value = 0.17). (B) Using the same approach, we show that GNL3L can also suppress the coactivator function of SRC2 on the ERRγ-dependent transcriptional activity in a dose-dependent (54% reduction for 100ng of GNL3L and 71% reduction for 200ng of GNL3L) and I-domain-dependent (P value = 0.58) manner. Error bars represent stand error of mean (s.e.m.). ***, P value < 0.0001.

Journal:

Article Title: GNL3L Inhibits Estrogen Receptor-Related Protein Activities by Competing for Coactivator Binding

doi: 10.1242/jcs.009878

Figure Lengend Snippet: (A) Using the same cell-based reporter system as described in Fig. 4, we show that the ERE-specific transcriptional activity in cells coexpressing ERRγ and SRC1 (8.0±0.3) is 1.7 times higher than that of the ERRγ-expressing sample (4.8±0.3). When coexpressed with the wild-type GNL3L (WT), this ERRγ and SRC1-mediated ERE-specific transcriptional activity is reduced by 55 and 70 percent compared to the sample expressing both ERRγ and SRC1 in a dose-dependent manner. This inhibitory effect of GNL3L on the SRC1-mediated coactivation of ERRγ requires the I-domain of GNL3L, as a deletion of this domain (dI) fails to suppress the transcriptional activity of ERRγ and SRC1 (P value = 0.17). (B) Using the same approach, we show that GNL3L can also suppress the coactivator function of SRC2 on the ERRγ-dependent transcriptional activity in a dose-dependent (54% reduction for 100ng of GNL3L and 71% reduction for 200ng of GNL3L) and I-domain-dependent (P value = 0.58) manner. Error bars represent stand error of mean (s.e.m.). ***, P value < 0.0001.

Article Snippet: Western analyses were performed using the mouse anti-Myc, rabbit anti-HA, rabbit anti-SRC1 (abcam, ab2859, 500X), and mouse anti-SRC2 (BD Transduction Laboratories, clone 29, 250X) antibodies.

Techniques: Activity Assay, Expressing

Our data reveal a novel mechanism that regulates the activity of ERR family genes by a nucleolar GTP-binding protein GNL3L. GNL3L decreases the transcriptional activity of ERR proteins. This event takes place in the nucleoplasm and does not require the nucleolar localization of GNL3L. The interaction between GNL3L and ERRγ displaces coactivators such as SRC1 and SRC2 from the ERRγ complex. The SRC-depleted ERRγ protein binds DNA without GNL3L, resulting in transcriptional inhibition. In this model, the nucleolar accumulation of GNL3L does not appear to affect its ability to suppress the transcriptional function of ERR proteins (grey arrows). Abbreviations for protein domains of GNL3L and ERR are explained in Fig. 2A and 2D.

Journal:

Article Title: GNL3L Inhibits Estrogen Receptor-Related Protein Activities by Competing for Coactivator Binding

doi: 10.1242/jcs.009878

Figure Lengend Snippet: Our data reveal a novel mechanism that regulates the activity of ERR family genes by a nucleolar GTP-binding protein GNL3L. GNL3L decreases the transcriptional activity of ERR proteins. This event takes place in the nucleoplasm and does not require the nucleolar localization of GNL3L. The interaction between GNL3L and ERRγ displaces coactivators such as SRC1 and SRC2 from the ERRγ complex. The SRC-depleted ERRγ protein binds DNA without GNL3L, resulting in transcriptional inhibition. In this model, the nucleolar accumulation of GNL3L does not appear to affect its ability to suppress the transcriptional function of ERR proteins (grey arrows). Abbreviations for protein domains of GNL3L and ERR are explained in Fig. 2A and 2D.

Article Snippet: Western analyses were performed using the mouse anti-Myc, rabbit anti-HA, rabbit anti-SRC1 (abcam, ab2859, 500X), and mouse anti-SRC2 (BD Transduction Laboratories, clone 29, 250X) antibodies.

Techniques: Activity Assay, Binding Assay, Inhibition